UPDATED Jun 02, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ESTA | US$52.23 | -2.4% | -22.0% | US$1.4b | US$63.00 | PS9.2x | E68.2% | n/a | ||
MYO | US$3.41 | -11.0% | 503.5% | US$98.3m | US$6.60 | PS5x | E66.0% | n/a | ||
HSCS | US$5.50 | -11.3% | -95.0% | US$3.6m | US$67.50 | PS193.9x | E66.8% | n/a | ||
ASTH | US$41.43 | 3.7% | 27.7% | US$2.0b | US$54.17 | PE32.5x | E24.9% | n/a | ||
NXGL | US$2.08 | -11.5% | -14.0% | US$13.0m | US$6.00 | PS2.7x | E67.5% | n/a | ||
ECOR | US$6.43 | -6.0% | 37.1% | US$38.6m | US$23.16 | PS2.1x | E69.5% | n/a | ||
GMED | US$67.11 | 2.0% | 21.0% | US$9.1b | US$71.17 | PE136x | E40.9% | n/a | ||
HIMS | US$19.42 | 15.0% | 117.0% | US$4.2b | US$17.33 | PS4.3x | E39.9% | n/a | ||
SLP | US$48.24 | -3.2% | 2.2% | US$964.1m | US$55.33 | PE91.7x | E30.0% | 0.5% | ||
AIRS | US$4.11 | 17.1% | -47.9% | US$236.6m | US$5.00 | PE151.3x | E53.8% | n/a | ||
VMD | US$7.41 | 5.0% | -24.5% | US$287.7m | US$12.75 | PE27.8x | E32.2% | n/a | ||
SRTS | US$5.42 | -11.1% | 103.8% | US$88.8m | US$9.00 | PE19.1x | E30.9% | n/a |